Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 12 Apr 24 424B5 Prospectus supplement for primary offering
- 11 Apr 24 424B5 Prospectus supplement for primary offering
- 7 Apr 23 EFFECT Notice of effectiveness
- 9 Feb 23 POS AM Prospectus update (post-effective amendment)
- 9 Feb 23 POSASR Automatic shelf registration (post-effective amendment)
- 8 Jul 22 424B5 Prospectus supplement for primary offering
- 8 Jul 22 424B5 Prospectus supplement for primary offering
-
4 Aug 21 S-3ASR Automatic shelf registration
NRIX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-3 of Nurix Therapeutics, Inc. of our report dated February 16, 2021 relating to the financial statements, which appears in Nurix Therapeutics, Inc.’s Annual Report on Form 10-K for the year ended November 30, 2020. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
San Jose, California
August 4, 2021